FINISHED DOSAGE FORMULATIONS
POLOXAMER 407
Route : INTRATYMPANIC
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 15.1
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 0.2
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 0.1
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 0.9
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 1
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 40
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 126
Potency Unit : MG/25.169GM
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397134
UNII : TUF2IVW3M2
Potency Amount : 50
Potency Unit : MG/5ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
29 Aug 2024
Reply
18 Jul 2023
Reply
28 Sep 2022
Reply
20 Oct 2021
Reply
26 Mar 2021